Ajanta Pharma Limited
Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic a… Read more
Ajanta Pharma Limited (AJANTPHARM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.066x
Based on the latest financial reports, Ajanta Pharma Limited (AJANTPHARM) has a cash flow conversion efficiency ratio of 0.066x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹2.84 Billion) by net assets (₹43.15 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ajanta Pharma Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Ajanta Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ajanta Pharma Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ajanta Pharma Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chongqing Brewery Co Ltd
SHG:600132
|
0.242x |
|
PACS Group, Inc.
NYSE:PACS
|
0.234x |
|
Xinxing Ductile Iron Pipes Co Ltd
SHE:000778
|
-0.010x |
|
Laboratorios Farmaceuticos Rovi S.A
PINK:LABFF
|
0.116x |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
0.021x |
|
Carmila SA
PA:CARM
|
0.031x |
|
Hyundai Elevator
KO:017800
|
0.043x |
|
Fujian Snowman Co Ltd
SHE:002639
|
-0.036x |
Annual Cash Flow Conversion Efficiency for Ajanta Pharma Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Ajanta Pharma Limited from 2005 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹37.90 Billion | ₹11.57 Billion | 0.305x | +38.73% |
| 2024-03-31 | ₹35.67 Billion | ₹7.85 Billion | 0.220x | -5.83% |
| 2023-03-31 | ₹33.88 Billion | ₹7.92 Billion | 0.234x | +35.73% |
| 2022-03-31 | ₹32.64 Billion | ₹5.62 Billion | 0.172x | -10.50% |
| 2021-03-31 | ₹29.96 Billion | ₹5.76 Billion | 0.192x | +9.46% |
| 2020-03-31 | ₹25.99 Billion | ₹4.57 Billion | 0.176x | +5.29% |
| 2019-03-31 | ₹22.45 Billion | ₹3.75 Billion | 0.167x | +19.39% |
| 2018-03-31 | ₹20.41 Billion | ₹2.85 Billion | 0.140x | -63.95% |
| 2017-03-31 | ₹15.68 Billion | ₹6.08 Billion | 0.388x | +39.29% |
| 2016-03-31 | ₹11.72 Billion | ₹3.26 Billion | 0.278x | -16.18% |
| 2015-03-31 | ₹8.41 Billion | ₹2.79 Billion | 0.332x | -7.21% |
| 2014-03-31 | ₹5.93 Billion | ₹2.12 Billion | 0.358x | -40.32% |
| 2013-03-31 | ₹3.93 Billion | ₹2.36 Billion | 0.600x | +133.59% |
| 2012-03-31 | ₹2.98 Billion | ₹765.41 Million | 0.257x | -41.57% |
| 2011-03-31 | ₹2.29 Billion | ₹1.01 Billion | 0.440x | -14.54% |
| 2010-03-31 | ₹1.85 Billion | ₹951.16 Million | 0.514x | +133.60% |
| 2009-03-31 | ₹1.57 Billion | ₹345.92 Million | 0.220x | +55.96% |
| 2008-03-31 | ₹1.35 Billion | ₹190.81 Million | 0.141x | -22.80% |
| 2007-03-31 | ₹1.16 Billion | ₹211.30 Million | 0.183x | -21.67% |
| 2006-03-31 | ₹1.09 Billion | ₹253.45 Million | 0.233x | +446.42% |
| 2005-03-31 | ₹978.24 Million | ₹-65.93 Million | -0.067x | -- |